Feature
BMJ investigation
From FDA to MHRA: are drug regulators for hire?
BMJ 2022; 377 doi: https://doi.org/10.1136/bmj.o1538 (Published 29 June 2022) Cite this as: BMJ 2022;377:o1538
Data supplement
Web Extra
- Data Supplement - Appendix: Supplement for table 1: methods
Related articles
- Letter Published: 27 September 2016; BMJ 354 doi:10.1136/bmj.i5055
- Feature Published: 23 October 2012; BMJ 345 doi:10.1136/bmj.e7163
- Editorial Published: 19 January 2022; BMJ 376 doi:10.1136/bmj.o102
- Feature Published: 16 September 2021; BMJ 374 doi:10.1136/bmj.n2059
- Research Published: 28 June 2016; BMJ 353 doi:10.1136/bmj.i3323
- News Published: 26 June 2020; BMJ 369 doi:10.1136/bmj.m2605
- Feature Published: 09 December 2020; BMJ 371 doi:10.1136/bmj.m4716
- Feature Published: 26 May 2021; BMJ 373 doi:10.1136/bmj.n1283
- Editor's Choice Published: 30 June 2022; BMJ 377 doi:10.1136/bmj.o1600
- Feature Published: 16 November 2022; BMJ 379 doi:10.1136/bmj.o2628
- Feature Published: 01 November 2023; BMJ 383 doi:10.1136/bmj.p2486
- News Published: 14 May 2024; BMJ 385 doi:10.1136/bmj.q1095
See more
- Galleri promises to detect multiple cancers—but new evidence casts doubt on this much hyped blood testBMJ August 07, 2024, 386 q1706; DOI: https://doi.org/10.1136/bmj.q1706
- Cord blood banking: Experts raise concern over claims made for stem cell applicationsBMJ July 24, 2024, 386 q1581; DOI: https://doi.org/10.1136/bmj.q1581
- Revolving door: You are free to influence us “behind the scenes,” FDA tells staff leaving for industry jobsBMJ July 01, 2024, 386 q1418; DOI: https://doi.org/10.1136/bmj.q1418
- How an opioid giant deployed a playbook for moulding doctors’ mindsBMJ June 10, 2024, 385 q1208; DOI: https://doi.org/10.1136/bmj.q1208
- Tobacco funded research: how even journals with bans find it hard to stem the tide of publicationsBMJ May 30, 2024, 385 q1153; DOI: https://doi.org/10.1136/bmj.q1153
Cited by...
- Mental health: MPs condemn overreliance on pills
- The FDA and Modernas cosy relationship: how lax rules enable a revolving door culture
- Serious harms of the COVID-19 vaccines: a systematic review
- FDA oversight of clinical trials is "grossly inadequate," say experts
- Death and ill health by order of the Supreme Court